EICHORCondition: Head and Neck Neoplasm · Carcinoma, Squamous Cell · Sponsor: UNC Lineberger Comprehensive Cancer Center
Circulating tumor DNA (ctDNA) is a blood-based test that measures dying or dead cancer cells that are already circulating in the blood. In this study, the investigators will enroll patients who are planning to receive surgery to remove their head and neck cancer. The investigators are interested to learn how ctDNA levels change with surgery and over the course of time. The investigators also want to determine if there are certain features of the tumor or the patient themselves that might cause ctDNA to be higher than other patients. Also, the investigators want to explore if the detection of ctDNA following surgery is related to cancer recurrence.
This description comes directly from the study's public registry record.
Siddharth Sheth, MD · (919) 966-3856 · Siddharth.Sheth@unchealth.unc.edu
Rebecca Green, MSW · (984) 974-8440 · rlgreen@med.unc.edu
Always discuss trial participation with your own doctor first.
| University of North Carolina at Chapel Hill | Chapel Hill, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04099290